S
NVO

Sachetta’s Novo Nordisk NVO Stock Holding History

Sachetta’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-178
Closed -$6.76K – 1155
2026
Q1 		$6.76K Hold
178
– – ﹤0.01% 560
2025
Q4 		$9.06K Hold
178
– – 0.01% 422
2025
Q3 		$9.88K Sell
178
-1
-0.6% -$59 ﹤0.01% 465
2025
Q2 		$12.4K Sell
179
-107
-37% -$7.28K ﹤0.01% 407
2025
Q1 		$20.2K Hold
286
– – 0.01% 347
2024
Q4 		$24.6K Hold
286
– – 0.01% 330
2024
Q3 		$34.1K Hold
286
– – 0.01% 312
2024
Q2 		$37K Sell
286
-39
-12% -$5.17K 0.02% 274
2024
Q1 		$33.6K Hold
325
– – 0.02% 269
2023
Q4 		$33.6K Buy
+325
New +$32.1K 0.02% 269

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Sachetta's NVO Position: Q2 2026 in Review

Sachetta sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 178 shares — an estimated $6.76K sold.

Sachetta first reported a position in NVO in Q4 2023 and held it in 10 quarters. The position peaked at $37K in Q2 2024. 243 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Sachetta reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 178 Novo Nordisk shares in Q2 2026, an estimated $6.76K.
  • Sachetta first reported a position in Novo Nordisk in Q4 2023 and held it in 10 quarters.
  • Sachetta's Novo Nordisk position peaked at $37K in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.